![]()
|
|
||||||||
(Received for publication, November 22, 1996, and in revised form, January 15, 1997)
From the A new member of the human cystatin superfamily,
called cystatin E, has been found by expressed sequence tag (EST)
sequencing in amniotic cell and fetal skin epithelial cell cDNA
libraries. The sequence of a full-length amniotic cell cDNA clone
contained an open reading frame encoding a putative 28-residue signal
peptide and a mature protein of 121 amino acids, including four
cysteine residues and motifs of importance for the inhibitory activity of Family 2 cystatins like cystatin C. Recombinant cystatin E was
produced in a baculovirus expression system and isolated. An antiserum
against the recombinant protein could be used for affinity purification
of cystatin E from human urine, as confirmed by N-terminal sequencing.
The mature recombinant protein processed by insect cells started at
amino acid 4 (cystatin C numbering), and displayed reversible
inhibition of papain and cathepsin B (Ki values of
0.39 and 32 nM, respectively), in competition with
substrate. Cystatin E is thus a functional cysteine proteinase inhibitor despite relatively low amino acid sequence similarities with
human cystatins (26-34% identity with sequences for the Family 2 cystatins C, D, S, SN, and SA; <30% with the Family 1 cystatins, A
and B, and domains 2 and 3 of the Family 3 cystatin, kininogen). Unlike
other human low Mr cystatins, cystatin E is a
glycoprotein, carrying an N-linked carbohydrate chain at
position 108. Northern blot analysis revealed that the cystatin E gene
is expressed in most human tissues, with the highest mRNA amounts
found in uterus and liver. A strikingly high incidence of cystatin E
clones in cDNA libraries from fetal skin epithelium and amniotic
membrane cells (>0.5% of clones sequenced) indicates a protective
role of cystatin E during fetal development.
Volume 272, Number 16,
Issue of April 18, 1997
pp. 10853-10858
©1997 by The American Society for Biochemistry and Molecular Biology, Inc.
,
,
,
,
,
,
,
,
,
,
,
and
Human Genome Sciences, Inc., Rockville,
Maryland 20850-3338 and the § Department of Clinical
Chemistry, Institute of Laboratory Medicine, University of Lund,
University Hospital, S-221 85 Lund, Sweden
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
L. Ai, W.-J. Kim, T.-Y. Kim, C. R. Fields, N. A. Massoll, K. D. Robertson, and K. D. Brown Epigenetic Silencing of the Tumor Suppressor Cystatin M Occurs during Breast Cancer Progression Cancer Res., August 15, 2006; 66(16): 7899 - 7909. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Cheng, K. Hitomi, I. M. J. J. van Vlijmen-Willems, G. J. de Jongh, K. Yamamoto, K. Nishi, C. Watts, T. Reinheckel, J. Schalkwijk, and P. L. J. M. Zeeuwen Cystatin M/E Is a High Affinity Inhibitor of Cathepsin V and Cathepsin L by a Reactive Site That Is Distinct from the Legumain-binding Site: A NOVEL CLUE FOR THE ROLE OF CYSTATIN M/E IN EPIDERMAL CORNIFICATION J. Biol. Chem., June 9, 2006; 281(23): 15893 - 15899. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Li, C. A. Putnam-Lawson, H. Knapp-Hoch, P. J. Friel, D. Mitchell, R. Hively, and M. D. Griswold Immunolocalization and Regulation of Cystatin 12 in Mouse Testis and Epididymis Biol Reprod, November 1, 2005; 73(5): 872 - 880. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Alvarez-Fernandez, Y.-H. Liang, M. Abrahamson, and X.-D. Su Crystal Structure of Human Cystatin D, a Cysteine Peptidase Inhibitor with Restricted Inhibition Profile J. Biol. Chem., May 6, 2005; 280(18): 18221 - 18228. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Zhang, R. Shridhar, Q. Dai, J. Song, S. C. Barlow, L. Yin, B. F. Sloane, F. R. Miller, C. Meschonat, B. D. L. Li, et al. Cystatin M: A Novel Candidate Tumor Suppressor Gene for Breast Cancer Cancer Res., October 1, 2004; 64(19): 6957 - 6964. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. L.J.M. Zeeuwen, I. M.J.J. van Vlijmen-Willems, D. Olthuis, H. T. Johansen, K. Hitomi, I. Hara-Nishimura, J. C. Powers, K. E. James, H. J. op den Camp, R. Lemmens, et al. Evidence that unrestricted legumain activity is involved in disturbed epidermal cornification in cystatin M/E deficient mice Hum. Mol. Genet., May 15, 2004; 13(10): 1069 - 1079. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Li, P. J. Friel, M. O. Robinson, D. J. McLean, and M. D. Griswold Identification and Characterization of Testis- and Epididymis-Specific Genes: Cystatin SC and Cystatin TE-1 Biol Reprod, December 1, 2002; 67(6): 1872 - 1880. [Abstract] [Full Text] [PDF] |
||||
![]() |
D.P. Dickinson SALIVARY (SD-TYPE) CYSTATINS: OVER ONE BILLION YEARS IN THE MAKING--BUT TO WHAT PURPOSE? Crit. Rev. Oral. Biol. Med., November 1, 2002; 13(6): 485 - 508. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. L.J.M. Zeeuwen, I. M.J.J. van Vlijmen-Willems, W. Hendriks, G. F.M. Merkx, and J. Schalkwijk A null mutation in the cystatin M/E gene of ichq mice causes juvenile lethality and defects in epidermal cornification Hum. Mol. Genet., November 1, 2002; 11(23): 2867 - 2875. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. HAN, J. NI, P. SMITS, C. B. UNDERHILL, B. XIE, Y. CHEN, N. LIU, P. TYLZANOWSKI, D. PARMELEE, P. FENG, et al. Extracellular matrix protein 1 (ECM1) has angiogenic properties and is expressed by breast tumor cells FASEB J, April 1, 2001; 15(6): 988 - 994. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Alvarez-Fernandez, A. J. Barrett, B. Gerhartz, P. M. Dando, J. Ni, and M. Abrahamson Inhibition of Mammalian Legumain by Some Cystatins Is Due to a Novel Second Reactive Site J. Biol. Chem., July 2, 1999; 274(27): 19195 - 19203. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Mukhopadhyay, J. Ni, Y. Zhai, G.-L. Yu, and B. B. Aggarwal Identification and Characterization of a Novel Cytokine, THANK, a TNF Homologue That Activates Apoptosis, Nuclear Factor-kappa B, and c-Jun NH2-Terminal Kinase J. Biol. Chem., June 4, 1999; 274(23): 15978 - 15981. [Abstract] [Full Text] [PDF] |
||||
![]() |
T.-L. Yue, J. Ni, A. M. Romanic, J.-L. Gu, P. Keller, C. Wang, S. Kumar, G.-l. Yu, T. K. Hart, X. Wang, et al. TL1, a Novel Tumor Necrosis Factor-like Cytokine, Induces Apoptosis in Endothelial Cells. INVOLVEMENT OF ACTIVATION OF STRESS PROTEIN KINASES (STRESS-ACTIVATED PROTEIN KINASE AND p38 MITOGEN-ACTIVATED PROTEIN KINASE) AND CASPASE-3-LIKE PROTEASE J. Biol. Chem., January 15, 1999; 274(3): 1479 - 1486. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Morita, N. Yoshiuchi, H. Arakawa, and S. Nishimura CMAP: A Novel Cystatin-like Gene Involved in Liver Metastasis Cancer Res., January 1, 1999; 59(1): 151 - 158. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Ni, M. A. Fernandez, L. Danielsson, R. A. Chillakuru, J. Zhang, A. Grubb, J. Su, R. Gentz, and M. Abrahamson Cystatin F Is a Glycosylated Human Low Molecular Weight Cysteine Proteinase Inhibitor J. Biol. Chem., September 18, 1998; 273(38): 24797 - 24804. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. Cornish, S. Freeman, G. Forbes, J. Ni, M. Zhang, M. Cepeda, R. Gentz, M. Augustus, K. C. Carter, and P. R. Crocker Characterization of Siglec-5, a Novel Glycoprotein Expressed on Myeloid Cells Related to CD33 Blood, September 15, 1998; 92(6): 2123 - 2132. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Haridas, J. Ni, A. Meager, J. Su, G.-L. Yu, Y. Zhai, H. Kyaw, K. T. Akama, J. Hu, L. J. Van Eldik, et al. Cutting Edge: TRANK, a Novel Cytokine That Activates NF-{kappa}B and c-Jun N-Terminal Kinase J. Immunol., July 1, 1998; 161(1): 1 - 6. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Halfon, J. Ford, J. Foster, L. Dowling, L. Lucian, M. Sterling, Y. Xu, M. Weiss, M. Ikeda, D. Liggett, et al. Leukocystatin, A New Class II Cystatin Expressed Selectively by Hematopoietic Cells J. Biol. Chem., June 26, 1998; 273(26): 16400 - 16408. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. W. Humke, J. Ni, and V. M. Dixit ERICE, a Novel FLICE-activatable Caspase J. Biol. Chem., June 19, 1998; 273(25): 15702 - 15707. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Stoka, B. Turk, S. L. Schendel, T.-H. Kim, T. Cirman, S. J. Snipas, L. M. Ellerby, D. Bredesen, H. Freeze, M. Abrahamson, et al. Lysosomal Protease Pathways to Apoptosis. CLEAVAGE OF Bid, NOT PRO-CASPASES, IS THE MOST LIKELY ROUTE J. Biol. Chem., January 26, 2001; 276(5): 3149 - 3157. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |